Pursuits
Behind Allergan, a Dealmaking CEO Ready to Win the Big Prize
- Brent Saunders has sold a company before and ended up as CEO
- From $25 billion to $120 billion company, and still going
Allergan Confirms Talks With Pfizer
This article is for subscribers only.
It’s almost as if Brent Saunders chose Ian Read, rather than the other way around.
Saunders, chief executive officer of Allergan Plc, has been busily reshaping his company in recent months, making it a better fit for Pfizer Inc., the venerable pharmaceutical giant that announced Thursday it’s in talks to acquire fast-growing Allergan.